INTRALASE FS2
Report
- Report Number
- 3006695864-2019-00872
- Event Type
- Injury
- Date Received
- November 4, 2019
- Date of Event
- October 15, 2019
- Report Date
- November 6, 2020
- Manufacturer
- JOHNSON & JOHNSON SURGICAL VISION, INC.
- Product Code
- HNO
- UDI-DI
- 05050474573451
- PMA / PMN Number
- K060372
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MN, US
- Reporter Occupation
- PHYSICIAN
Narratives
THIS CORRECTION MDR IS BEING SUBMITTED TO ADDRESS INACCURATE INFORMATION IN SECTION F ON THE XML VERSION OF THE PREVIOUS SUBMISSION CAUSED BY A SOFTWARE GLITCH IN THE TRANSMISSION PROCESS. THE INTERNAL NON-CONFORMANCE NUMBERS FOR THIS SOFTWARE ISSUE ARE NR-0148919 AND CAPA-010215.
(B)(4). A REVIEW OF RECORDS RELATED TO THE DEVICE INCLUDING LABELING, COMPLAINT TRENDING, AND RISK DOCUMENTATION WILL BE PERFORMED. UPON COMPLETION OF THIS REVIEW, IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED. ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC. HAS BEEN SUBMITTED.
IT WAS REPORTED THAT A LASER VISION CORRECTION PATIENT HAD SURGERY ON (B)(6) 2019 AND PRESENTED ON (B)(6) 2019 WITH LOOSE EPITHELIUM OF BOTH EYES. THERE WAS IRREGULAR EPITHELIUM AND HAZE OF THE RIGHT EYE AND EPITHELIAL BASEMENT MEMBRANE DYSTROPHY (EBMD) OF BOTH EYES. BANDAGE CONTACT LENSES WERE PLACE IN BOTH EYES. THE PATIENT REPORTED BLURRY VISION WITH THE RIGHT EYE GREATER THAN THE LEFT AND HAD CONCERNS WITH OUTCOMES. IT WAS STATED THAT THE PATIENT DID NOT EXPERIENCE LOSS OF BEST CORRECTED VISUAL ACUITY (BCVA). PATIENT SYMPTOMS WERE NOT INTERFERING WITH DAILY ACTIVITIES. BCVA FROM (B)(6) 2019: RIGHT EYE PRE-OP 20/20 -6.75 X -1.75 X 7, LEFT EYE PRE-OP 20/20 -7.50 X -.50 X 3.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1065881 | INTRALASE FS2 | FEMTOSECOND LASER | HNO | JOHNSON & JOHNSON SURGICAL VISION, INC. | 20005D | 05050474573451 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 30 YR | Required Intervention | WAVELIGHT 1010-3-259 |